NCT02764086 2026-04-13
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Cancer Trials Ireland
Phase 1/2 Terminated
Cancer Trials Ireland
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Proton Collaborative Group
Vanderbilt-Ingram Cancer Center
Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre
University of Washington
Clinical Oncology Research Associates
Eli Lilly and Company